Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Wendy, Komocsar"'
Autor:
Theresa Hunter, Wendy Komocsar, Richard Colletti, Chunyan Liu, Keith Benkov, Jennifer Dotson, Steven Steiner, Nanhua Zhang, Wallace Crandall
Publikováno v:
Inflammatory Bowel Diseases. 27:S22-S23
Objectives The objective of this study was to assess current treatment patterns of pediatric ulcerative colitis (UC) and Crohn’s disease (CD) patients, using data in the ImproveCareNow (ICN) registry. Methods Pediatric (2–17 years) patients in th
Autor:
Theresa Hunter, Wendy Komocsar, Chunyan Liu, Richard Colletti, Steven Steiner, Jennifer Dotson, Keith Benkov, Nanhua Zhang, Wallace Crandall
Publikováno v:
Inflammatory Bowel Diseases. 27:S12-S13
Objectives To assess disease activity, steroid-free remission, and clinical outcome assessments among pediatric UC and CD patients who initiated a biologic after being enrolled in the ICN registry. Methods Pediatric patients who were diagnosed with U
Autor:
Narayanan B. Perumal, Richard E. Higgs, Marta E. Alarcón-Riquelme, Matthew D. Linnik, Ernst R. Dow, Joan T. Merrill, Laura Nisenbaum, E Nantz, M. Petri, David C. Airey, Yushi Liu, Guilherme Rocha, Krista Schroeder, W D O Robert Hoffman, J B S Wendy Komocsar
Publikováno v:
Arthritis & Rheumatology. 69:643-654
Objective To characterize baseline gene expression and pharmacodynamically induced changes in whole blood gene expression in 1,760 systemic lupus erythematosus (SLE) patients from 2 phase III, 52-week, randomized, placebo-controlled, double-blind stu
Autor:
Christopher P. Cannon, Clement Maurath, Richard A. Cooper, Richard H. Aster, John Ferguson, Edward Swabb, Maria Ehardt, Wendy Komocsar, Stuart Kupfer, Brian R. Curtis, Jacqueline A. Brassard
Publikováno v:
Thrombosis and Haemostasis. 88:892-897
SummaryThrombocytopenic episodes occurring in 18,845 patients treated with the GPIIb/IIIa inhibitors xemilofiban and orbofiban (“fibans”) were analyzed by a blinded review panel and 73 patients were classified as having “possible fiban-induced
Autor:
Holden T, Maecker, J Philip, McCoy, Michael, Amos, John, Elliott, Adolfas, Gaigalas, Lili, Wang, Richard, Aranda, Jacques, Banchereau, Chris, Boshoff, Jonathan, Braun, Yael, Korin, Elaine, Reed, Judy, Cho, David, Hafler, Mark, Davis, C Garrison, Fathman, William, Robinson, Thomas, Denny, Kent, Weinhold, Bela, Desai, Betty, Diamond, Peter, Gregersen, Paola, Di Meglio, Paola, DiMeglio, Frank O, Nestle, Frank, Nestle, Mark, Peakman, Federica, Villanova, Federica, Villnova, John, Ferbas, Elizabeth, Field, Aaron, Kantor, Thomas, Kawabata, Wendy, Komocsar, Michael, Lotze, Jerry, Nepom, Hans, Ochs, Raegan, O'Lone, Deborah, Phippard, Scott, Plevy, Stephen, Rich, Mario, Roederer, Dan, Rotrosen, Jung-Hua, Yeh
Publikováno v:
Nature immunology. 11(11)
Complexities in sample handling, instrument setup and data analysis are barriers to the effective use of flow cytometry to monitor immunological parameters in clinical trials. The novel use of a central laboratory may help mitigate these issues.
Autor:
Jacqueline A, Brassard, Brian R, Curtis, Richard A, Cooper, John, Ferguson, Wendy, Komocsar, Maria, Ehardt, Stuart, Kupfer, Clement, Maurath, Edward, Swabb, Christopher P, Cannon, Richard H, Aster
Publikováno v:
Thrombosis and haemostasis. 88(6)
Thrombocytopenic episodes occurring in 18,845 patients treated with the GPIIb/IIIa inhibitors xemilofiban and orbofiban ("fibans") were analyzed by a blinded review panel and 73 patients were classified as having "possible fiban-induced thrombocytope